JAN 23, 2018 12:00 PM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
WEBINAR: Bringing Novel Biomarkers from Research to Clinical Use
SPONSORED BY: Sphingotec LLC
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
2 4 172

Speakers:
  • Chair of the Division of Clinical Core Laboratory Services in the Department of Laboratory Medicine , Mayo Clinic College of Medicine
    Biography
      Allan S. Jaffe, M.D., is a Consultant and Chair of the Division of Clinical Core Laboratory Services at Mayo Clinic in Rochester, Minnesota, with a joint appointment in the Department of Cardiovascular Diseases. He holds the academic rank of Professor of Laboratory Medicine and Pathology and also Professor of Medicine.
    • Co-Director, Cardiovascular Laboratory Medicine, Mayo Clinic
      Biography
        Dr. Meeusen received a PhD from the University of Wisconsin studying inorganic biochemistry. After graduate school he spent three years as a post-doctoral research fellow supporting Mayo Medical Laboratories esoteric test development. Dr. Meeusen's research interests include lipid and lipoprotein testing and he is currently co-director of Cardiovascular Laboratory Medicine at Mayo Clinic.
      • Co-Director of the Cardiovascular Laboratory Medicine and Co-Director of the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic in Rochester
        Biography
          Leslie J. Donato, Ph.D., DABCC, Co-Director of the Cardiovascular Laboratory Medicine and Co-Director of the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic in Rochester, Minnesota. She is a Consultant in the Division of Clinical Core Laboratory Services in the Department Laboratory Medicine and Pathology.

        Abstract:

        DATE: January 23, 2018
        TIME: 12:00 PM PST, 3:00 PM EST

        The translation of basic scientific research to clinical application in the hospital or clinic setting is vital for advancing the quality of patient care. This is particularly true in the clinical laboratory when hospital labs evaluate new biomarkers for potential clinical use as a laboratory developed test (LDT).

        The numerous steps taken to evaluate the analytical and clinical performance of each novel biomarker are critical to this process before the test can be ordered. These steps ensure the test results are accurate and reproducible when performed by laboratory technologists and confirm that results can be used to improve disease diagnostics or prognostics.

        Here we will describe the process a major academic medical center takes to critically evaluate novel biomarkers for various clinical applications and provide examples of such novel biomarkers that are either under evaluation or have been recently completed.

        Learning Objectives:

        • Understand what factors are important to consider when deciding which novel biomarker to evaluate for clinical use
        • Understand the importance and challenges of analytical validations of assays for novel biomarkers
        • Understand the importance and challenges of clinical validations of assays for novel biomarkers

        Show Resources
        Loading Comments...